Frank T. Kagawa

Rhabdomyolysis associated with 2009 influenza A(H1N1).

dations for the management of patients with herpes zoster recommend using antiviral therapy to decrease the incidence of PHN,” citing an article for which I am a coauthor. This article stated that antiviral therapy should be used to treat patients with herpes zoster and that it had an impact on acute neuritis. Although the guidelines concluded that the use of antiviral therapy may have an effect on “chronic pain,” this therapy was not sufficient to uniformly prevent PHN. As noted here, the FDA reached a similar conclusion. The goal of management of herpes zoster is to accelerate healing, prevent complications, and decrease pain—both acute pain and PHN. With the evidence available from existing antiviral studies, these end points have been achieved with the exception of prevention of PHN. The management of PHN is of critical importance for individuals who have herpes zoster. Consideration of combination therapy at the onset of disease, particularly in patients with severe acute pain, needs to be further evaluated. Future treatment strategies may prevent or provide more significant relief for this potentially devastating complication.

An unusual complication during central venous catheter placement

A 31-year-old man with disseminated Coccidioides imitis infection required central catheter placement for access. The patient had an inferior vena cava (IVC) filter placed as a result of previous deep venous thrombosis of the left lower extremity. The guidewire could not be removed following placement of the right internal jugular catheter by the Seldinger technique. Fluoroscopic examination revealed entanglement of the J-tip guidewire in the apex of the IVC filter. The catheter was successfully removed by interventional radiologists using a snare tip catheter through the left femoral vein.

Improving Patient Safety to Reduce Preventable Deaths: The Case of a California Safety Net Hospital

&NA; Preventable deaths occur when signs and symptoms of risk and decline are not detected yet are present many hours prior to a deteriorating course. Rapid responses teams (RRTs), also referred to as medical emergency teams (METs) were introduced to improve patient safety by preventing code arrests and death. This research using a case study methodology describes a nurse‐led RRT, developed at a large, safety net, teaching hospital in California. Safety‐net hospitals are challenged to deliver care and meet the complex needs of vulnerable patient populations. This hospital is a mission driven organization that is focused on the patient and the needs of underserved populations. To respond to the call for reform for patient safety and reduce adverse events, the organization adopted RRTs, early recognition rounds by RRT registered nurses (RNs) and the use of trigger alerts by nursing assistants (NAs) to expand the surveillance and identification of patients most at risk of clinical deterioration. Collaboration with interns and residents (house staff) facilitated their involvement and response to RRT calls. Using quality data from 2005 to 2010, findings from this patient safety innovation address RRT utilization, frequency of non‐ICU code arrests, hospital mortality, and post‐arrest survival outcomes.

Prophylaxis of aerosolized pentamidine-induced bronchospasm: a symptom-based approach.

The frequent occurrence of bronchospasm due to aerosolized pentamidine (AP) may reduce delivery of drugs to distal airways and produce symptoms that limit therapy. This study performed spirometric measurements before and after AP treatment in 30 human immunodeficiency virus seropositive patients over 18 months. Patients reporting symptoms of bronchospasm were treated with prophylactic beta-agonist aerosol before subsequent AP treatment. Forty percent of patients reported symptoms. This group had significant declines in forced expiratory volume in 1 second associated with AP, whereas the asymptomatic group had no decline in forced expiratory volume in 1 second. Bronchodilator prophylaxis eliminated AP-induced symptoms and spirometric changes. Baseline spirometry did not change after five monthly treatments. The close relationship between symptoms and acute spirometric changes, the lack of progressive airway obstruction due to AP, and the reliable response to beta-agonist therapy make a symptom-based approach to treatment possible.